New therapeutic approach by G2013 in experimental model of multiple sclerosis

Cytokine production profiles in chronic relapsing–remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse

(2014) Yoshihiko Hidaka et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Advances in Antioxidative Therapy of Multiple Sclerosis

(2013) E. Miller et al.   CURRENT MEDICINAL CHEMISTRY

Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice

(2011) STEFANIE KUERTEN et al.   APMIS

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

(2011) Cris S Constantinescu et al.   BRITISH JOURNAL OF PHARMACOLOGY

A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis

(2011) Ivana Nikić et al.   NATURE MEDICINE

Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis

(2010) Áine C. Murphy et al.   BRAIN BEHAVIOR AND IMMUNITY

Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies

(2010) Dirk Fitzner et al.   Current Neuropharmacology

Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary

(2008) Rocio S. Lopez-Diego et al.   NATURE REVIEWS DRUG DISCOVERY

Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis

(2008) Masayuki Moriya et al.   NEUROSCIENCE LETTERS

Glia maturation factor overexpression in neuroblastoma cells activates glycogen synthase kinase-3β and caspase-3

(2007) Asgar Zaheer et al.   BRAIN RESEARCH